Location
United States, North America
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
Health IT
Health & Hospital Services
Digital Health
BioTech
Consumer Health
Pharmaceuticals
About Investor
Peter Svennilson serves as Managing Partner and Founder at The Column Group, focusing on investments in Consumer Health, Pharmaceuticals, BioTech, Health IT, Health & Hospital Services, and Digital Health sectors at seed, Series A, and Series B stages with investment ranges between $100K and $5.0M. Svennilson founded The Column Group in 2007 and has 23 years of experience in corporate venture capital, leading a biotech VC fund based in San Francisco that manages over $4 billion in assets and is dedicated to creating the next generation of biotechnology companies.
Previous investments
Circle Pharma
90M |2024
66M |2021
45M |2020
NGM Biopharmaceuticals
120M |2024
58M |2015
55M |2010
27M |2009
Carmot Therapeutics
160M |2022
47M |2020
15M |2018
2M |2010
Similar Investors
AL
Abdul Ly
United States, North America
$1M - $4M
Seed
,Series A
,PS
Paul Straub
United States, North America
$100K - $2M
Pre Seed
,Seed
,SA
Shaun Abrahamson
United States, North America
$250K - $1M
Pre Seed
,Seed
,RF
Riley Florsheim
United States, North America
$100K - $5M
Pre Seed
,Seed
,SB
Steve Brownlie
United States, North America
$250K - $1.4M
Pre Seed
,Seed
,DG
Danielle Graham
Canada, North America
$100K - $300K
Pre Seed
,Seed
,Is this Your Profile?
If you have any updates, please fill out our form.